Assignee
TERRAN BIOSCIENCES INC
US·11 granted patents·39 pending applications·4 citations·filing 2019–2025
Top patents by PatentIndex Score
50 records- 0190US11958821B2Phenethylamine compounds salts, polymorphic forms and methods of use thereofTERRAN BIOSCIENCES INC·Filed 2023·Granted Apr 16, 2024·2 cites·25 claims
- 0281US12577222B2Phenethylamine compounds salts, polymorphic forms and methods of use thereofTERRAN BIOSCIENCES INC·Filed 2024·Granted Mar 17, 2026·0 cites·38 claims
- 0379US12435036B2Salts and solid forms of (R)-1-(5-methoxy-1H-indol-1-yl)-n,n-dimethylpropan-2-amineTERRAN BIOSCIENCES INC·Filed 2024·Granted Oct 7, 2025·0 cites·14 claims
- 0479US12079960B2Systems, devices, and methods for harmonization of imaging datasets including biomarkersTERRAN BIOSCIENCES INC·Filed 2022·Granted Sep 3, 2024·2 cites·18 claims
- 0579US2024409526A1Phenethylamine compounds salts, polymorphic forms and methods of use thereofTERRAN BIOSCIENCES INC·Filed 2024·Application pending·0 cites
- 0678US11945832B2Psilocybin and O-acetylpsilocin, salts and solid state forms thereofTERRAN BIOSCIENCES INC·Filed 2023·Granted Apr 2, 2024·0 cites·18 claims
- 0776US2026008797A1Processes of preparing psilocin and psilocybinTERRAN BIOSCIENCES INC·Filed 2025·Application pending·0 cites
- 0876US2026078090A1N-substituted indoles as 5-hydroxytryptamine (5-ht) serotonin receptor agonists and antagonistsTERRAN BIOSCIENCES INC·Filed 2025·Application pending·0 cites
- 0975US12319652B2Salts and solid forms of (R)-1-(5-methoxy-1H-indol-1-yl)-N,N-dimethylpropan-2-amineTERRAN BIOSCIENCES INC·Filed 2023·Granted Jun 3, 2025·0 cites·30 claims
- 1075US12234216B2Isotopologues salts, crystalline forms, stereoisomers, of methylone and ethylone and methods of use thereofTERRAN BIOSCIENCES INC·Filed 2022·Granted Feb 25, 2025·0 cites·14 claims
- 1175US11851452B2Psilocybin and O-acetylpsilocin, salts and solid state forms thereofTERRAN BIOSCIENCES INC·Filed 2022·Granted Dec 26, 2023·0 cites·28 claims
- 1275US2023202998A1Phenethylamine compounds salts, polymorphic forms and methods of use thereofTERRAN BIOSCIENCES INC·Filed 2022·Application pending·0 cites
- 1373US12269818B2Analogs of xanomelineTERRAN BIOSCIENCES INC·Filed 2024·Granted Apr 8, 2025·0 cites·42 claims
- 1473US2026000641A1Isotopically enriched analogs of 5,6-methylenedioxy-2-aminoindane (imdai)TERRAN BIOSCIENCES INC·Filed 2025·Application pending·0 cites
- 1572US2024002337A1Salts and solid forms of (r)-1-(5-methoxy-1h-indol-1-yl)-n,n-dimethylpropan-2-amineTERRAN BIOSCIENCES INC·Filed 2022·Application pending·0 cites
- 1672US2025011351A1Psilocybin and o-acetylpsilocin, salts and solid state forms thereofTERRAN BIOSCIENCES INC·Filed 2022·Application pending·0 cites
- 1772US2026085041A1Salts and solid forms of 4-hydroxy-n,n-diisopropyltryptamine hemi-glutarate and hemi-succinateTERRAN BIOSCIENCES INC·Filed 2025·Application pending·0 cites
- 1871US11905295B2Solid forms of tabernanthalog monofumarate salt for treating neurological disorders and/or psychiatric disordersTERRAN BIOSCIENCES INC·Filed 2023·Granted Feb 20, 2024·0 cites·28 claims
- 1970US11866408B2N,N-dimethyltryptamine and related psychedelics and uses thereofTERRAN BIOSCIENCES INC·Filed 2023·Granted Jan 9, 2024·0 cites·28 claims
- 2069US2024317783A1Processes of preparing psilocin and psilocybinTERRAN BIOSCIENCES INC·Filed 2022·Application pending·0 cites
- 2168US2023159456A1N-substituted indolesTERRAN BIOSCIENCES INC·Filed 2022·Application pending·0 cites
- 2268US2024116870A1N,n-dimethyltryptamine and related psychedelics and uses thereofTERRAN BIOSCIENCES INC·Filed 2023·Application pending·0 cites
- 2368US2025066299A1Salts and solid forms of 4-hydroxy-n,n-diisopropyltryptamine hemi-glutarate and hemi-succinateTERRAN BIOSCIENCES INC·Filed 2023·Application pending·0 cites
- 2467US2026092060A1Isotopically enriched analogs of 2-bromo-lsd, lsd, ald-52, and 1p-lsdTERRAN BIOSCIENCES INC·Filed 2025·Application pending·0 cites
- 2567US2023150965A1Isotopically enriched n-methyl-1,3-benzodioxolylbutanamine (mbdb) and stereoisomers thereofTERRAN BIOSCIENCES INC·Filed 2022·Application pending·0 cites
- 2667US2023257385A1Salt and solid forms of tabernanthalogTERRAN BIOSCIENCES INC·Filed 2022·Application pending·0 cites
- 2766US2025109130A1Isotopically enriched analogs of 2-bromo-lsd, lsd, ald-52, and 1p-lsdTERRAN BIOSCIENCES INC·Filed 2022·Application pending·0 cites
- 2866US2024400512A1Analogs of n,n,n-trimethyl-4-phosphoryloxytryptamineTERRAN BIOSCIENCES INC·Filed 2024·Application pending·0 cites
- 2966US2025034105A1Isotopically enriched n-methyl-1,3-benzodioxolylbutanamine (mbdb) and stereoisomers thereofTERRAN BIOSCIENCES INC·Filed 2024·Application pending·0 cites
- 3065US2023181521A1Isotopically enriched analogs of 5,6-methylenedioxy-2-aminoindane (mdai)TERRAN BIOSCIENCES INC·Filed 2022·Application pending·0 cites
- 3165US2024294488A1Isotopologes, salts, crystalline forms, stereoisomers, of methylone and ethylone and methods of use thereofTERRAN BIOSCIENCES INC·Filed 2023·Application pending·0 cites
- 3265US2023150936A1Analogs of n,n,n-trimethyl-4-phosphoryloxytryptamineTERRAN BIOSCIENCES INC·Filed 2022·Application pending·0 cites
- 3365US2026007323A1Neuromelanin-sensitive mri for assessing parkinson's diseaseTERRAN BIOSCIENCES INC·Filed 2025·Application pending·0 cites
- 3461US2023159544A1Azepino-indoles for the treatment of neurological and psychiatric disordersTERRAN BIOSCIENCES INC·Filed 2022·Application pending·0 cites
- 3561US2025091993A1Salts and solid forms of n-ethyl-2-(5-fluoro-1h-indol-3-yl)-n-methylethan-1-amineTERRAN BIOSCIENCES INC·Filed 2023·Application pending·0 cites
- 3660US2025129064A1Prodrugs of 2-bromo-lsd (2-bromolysergic acid diethylamide)TERRAN BIOSCIENCES INC·Filed 2023·Application pending·0 cites
- 3760US2025195477A1Deuterated idazoxan and methods of use thereofTERRAN BIOSCIENCES INC·Filed 2023·Application pending·0 cites
- 3860US2025136548A1Functionalized alkylaminesTERRAN BIOSCIENCES INC·Filed 2023·Application pending·0 cites
- 3959US2025129054A1Prodrugs of 3,4-methylenedioxy-n-methcathinone and uses thereofTERRAN BIOSCIENCES INC·Filed 2023·Application pending·0 cites
- 4059US2025049748A1Analogs of 4-bromo-2,5-dimethoxyphenethylamineTERRAN BIOSCIENCES INC·Filed 2022·Application pending·0 cites
- 4159US2023150966A1Isotopically enriched 3,4-methylenedioxy-n-ethylamphetamine (mde) and stereoisomers thereofTERRAN BIOSCIENCES INC·Filed 2022·Application pending·0 cites
- 4253US2025011344A1Prodrugs and derivatives of psilocin and uses thereofTERRAN BIOSCIENCES INC·Filed 2022·Application pending·0 cites
- 4351US2024317724A13,4-methylenedioxymethamphetamine and related psychedelics and uses thereofTERRAN BIOSCIENCES INC·Filed 2022·Application pending·0 cites
- 4450US2023150920A1Salts and solid forms of 4-bromo-2,5-dimethoxyphenethylamineTERRAN BIOSCIENCES INC·Filed 2022·Application pending·0 cites
- 4549US2022106272A1Deuterated Forms And Derivatives Of VolinanserinTERRAN BIOSCIENCES INC·Filed 2019·Application pending·0 cites
- 4648US2024197681A1Methods and compositions relating to psychedelics and serotonin receptor modulatorsTERRAN BIOSCIENCES INC·Filed 2022·Application pending·0 cites
- 4745US2022273184A1Neuromelanin-sensitive mri for assessing parkinson's diseaseTERRAN BIOSCIENCES INC·Filed 2020·Application pending·0 cites
- 4845US2023389854A1Neuromelanin-sensitive mri and methods of use thereofTERRAN BIOSCIENCES INC·Filed 2023·Application pending·0 cites
- 4943US2024294460A1Deuterated analogs and derivatives of 4-bromo-2,5-dimethoxyphenethylamine and uses thereofTERRAN BIOSCIENCES INC·Filed 2022·Application pending·0 cites
- 5043US2024000795A1Methods and compositions relating to controlling psychedelic effects with serotonin receptor modulatorsTERRAN BIOSCIENCES INC·Filed 2022·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when TERRAN BIOSCIENCES INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →